Methods
We included 100 randomly selected adult DOAC users visiting one of the
two participating Dutch community pharmacies in the summer of 2020. The
self-reported adherence (primary outcome) was assessed with the
Medication Adherence Rating Scale-5 (MARS-5). Beliefs about DOACs were
assessed with the Beliefs about Medicine Questionnaire Specific (BMQ-S)
while side effects were assessed with a self-developed questionnaire
based on the Lareb Intensive Monitoring (LIM) system.